The Food and Drug Administration Friday authorized the first COVID-19 test to identify and differentiate certain SARS-CoV-2 lineages in respiratory samples that test positive for the virus. The emergency use authorization (allows certain laboratories certified under the Clinical Laboratory Improvement Amendments to perform the Labcorp next generation sequencing test.
 

Related News Articles

Headline
AHA will co-host a Sept. 27 Facebook Live event with AdventHealth on the importance of getting children vaccinated and boosted against COVID-19, which will…
Headline
In-hospital mortality among patients hospitalized primarily for COVID-19 fell from 15.1% during the delta period to 4.9% this April through June, the Centers…
Headline
As labor shortages and inflation drive up expenses, U.S. hospitals and health systems this year face the worst financial crisis since the COVID-19 pandemic…
Headline
Insured and uninsured Americans can receive the new bivalent Pfizer or Moderna COVID-19 booster and other COVID-19 vaccines at no cost as long as the federal…
Headline
The Biden Administration will make over 170 million doses of the bivalent COVID-19 vaccine booster available to Americans for free at pharmacies, doctor’s…
Headline
The Centers for Medicare & Medicaid Services seeks comments through Nov. 4 on the challenges individuals face accessing health care services through…